This protocol is judged by an institutional review board, an impartial team that evaluations any clinical trials involving people. If a review entails a Agenda I drug, as soon as the board approves the protocol as moral, the scientists must make an application for an investigational new drug (IND) amount within the FDA.Therefore, medicine will oft